Key points from article :
Prostate cancer is the most common cancer affecting men in the UK, with 47,000 new cases a year.
About 75% PSA test results are false positive.
PSA misses cancer in about 15% of men with prostate cancer.
Prostate urine risk (PUR) test looks for genetic markers to give a more accurate assessment.
Post‐digital rectal examination urine‐derived EV‐RNA expression profiles were interrogated.
There are 4 PUR signatures, each of them was significantly associated with its corresponding clinical category.
Trial is based on 537 men.
Researchers hope the urine test will become available in 3 years for doctors for use in daily practice.
The study was published in BJU International journal.
